Bonavista Energy Corporation Report on Voting from the 2013

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Bonavista Energy Corporation Report on Voting from the 2013 Shareholders Meeting

CALGARY, ALBERTA--(Marketwired - May 3, 2013) - Bonavista Energy Corporation ("Bonavista" or the "Corporation") (TSX:BNP) announces that the following matters were voted upon at the annual and special meeting of the shareholders of Bonavista held on May 2, 2013 in Calgary, Alberta. Each of the matters is described in greater detail in the Notice of Annual and Special Meeting of Shareholders and Information Circular dated March 22, 2013 (the "Circular").

1. Election of Directors

By resolution passed via ballot, the following nine nominees were appointed as Directors of the Corporation to serve until the next annual meeting of shareholders of the Corporation, or until their successors are elected or appointed. The results of the ballot were as follows:

Name of Nominee Votes For Percent Votes Withheld Percent
Keith A. MacPhail 125,135,606 99.37 788,539 0.63
Ronald J. Poelzer 124,735,369 99.06 1,188,776 0.94
Ian S. Brown 123,520,294 98.09 2,403,851 1.91
Michael M. Kanovsky 116,196,082 92.27 9,728,063 7.73
Harry L. Knutson 116,953,452 92.88 8,970,693 7.12
Margaret A. Mckenzie 125,628,964 99.77 295,181 0.23
Jason E. Skehar 125,643,267 99.78 280,878 0.22
Christopher P. Slubicki 116,852,451 92.80 9,071,694 7.20
Walter C. Yeates 125,627,906 99.76 296,239 0.24

2. Appointment of Auditors

By resolution passed via ballot, KPMG LLP, Chartered Accountants, were appointed as auditors of the Corporation to hold office until close of the next annual meeting or until their successors are duly appointed, and the directors were authorized to fix their remuneration. The results of the ballot were as follows:

Votes For Percent Votes Withheld Percent
126,896,081 99.74 330,192 0.26

3. 2013 Incentive Award Plan

By resolution passed via ballot, the 2013 incentive award plan of the Corporation as described in the Circular was approved. The results of the ballot were as follows:

Votes For Percent Votes Withheld Percent
95,811,574 76.09 30,111,243 23.91

4. Stock Option Plan Amendments

By resolution passed via ballot, certain amendments to the Corporation's stock option plan, including the conversion of the stock option plan from a rolling plan to a fixed plan, as described in the Circular were approved. The results of the ballot were as follows:

Votes For Percent Votes Withheld Percent
98,465,718 78.20 27,457,099 21.80

Bonavista is a mid-sized energy corporation committed to maintaining its emphasis on operating high quality oil and natural gas properties, providing moderate growth and delivering consistent dividends to its shareholders and ensuring financial strength and sustainability.

Keith A. MacPhail Executive Chairman (403) 213-4300 Jason E. Skehar President & CEO (403) 213-4300 Glenn A. Hamilton Senior Vice President & CFO (403) 213-4300 Bonavista Energy Corporation 1500, 525 - 8th Avenue SW Calgary, AB T2P 1G1 www.bonavistaenergy.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leqembi Pen Revolutionizes Alzheimer's Care in Japan

Updated Category News Views 22

Innovative Alzheimer's Treatment Hits Japanese Market Just when you think the medical world needs a jolt of innovation, BioArctic rolls out something that could change how Alzheimer's is managed. With their subcutaneous Leqembi Pen, they've just added another feather in their cap, launching in Japan after a successful U.S. introduction. Not just your run-of-the-mill...

Continue Reading
Randi Baptiste Sets a New Standard in Youth Sports

Updated Category News Views 62

Youth Sports: Revolutionized by Randi Baptiste In an era where youth sports face a minefield of health risks and performance pressures, Randi Baptiste stands out. This isn't just about running around the park—this is about fundamentally transforming how we think about athletic development for young folks. Recognizing Baptiste for his contributions, The Inner Circle...

Continue Reading
Simform's AI Innovations Earns Microsoft Award Nod

Updated Category News Views 64

Riding the AI Wave with Simform In the chaotic world of AI and tech partnerships, earning recognition from a powerhouse like Microsoft ain't your run-of-the-mill achievement. Simform being recognized as a finalist for the 2026 Microsoft Innovate with Azure AI Apps and Agents Partner of the Year Award is a big deal, not just for them, but as a beacon of inspiration for...

Continue Reading
GAC's Green Push Unveils 3rd Showroom in Casablanca

Updated Category News Views 146

Pushing Through North Africa's Automotive Shift Well, looks like GAC is showing they're not just dabbling in North Africa—they're planting some sturdy roots in that rocky soil. Opening their third showroom in Casablanca, GAC isn't just settling for sidelines. They're step-in-the-ring serious about carving their name on North African roads. This isn't some skin-deep...

Continue Reading
Adam Foundation's Ramadan Effort to Cut Plastic Waste

Updated Category News Views 27

Environmental Consciousness: A Call from Antalya Here we go again, folks. Something refreshing is brewing over in Antalya at COP31, where the UK-based Adam Foundation has made a move that resonates beyond the usual hubbub. No smoke and mirrors, just straightforward action aimed at cutting down the wave of plastic waste during Ramadan. This isn't some pie-in-the-sky green...

Continue Reading
FF EAI Robotics Aims for Top Spot in K-12 Tech

Updated Category News Views 28

FFR's Shot at Robotics Education Dominance You ever feel like a company is throwing everything but the kitchen sink at an opportunity? That's FF EAI Robotics for you—charging ahead with a hefty laundry list of tech ambitions. They've clocked in about $2.3 million in revenue from their newly acquired robotics wing for the first nine months of 2026, showing a 26% gross...

Continue Reading
Rethinking Risk: AI, Cyber, and Ops Convergence

Updated Category News Views 28

Risk Management's New Frontier Hold onto your hats, folks, because the landscape of risk management is shifting under our feet—and not a minute too soon. With AI adoption skyrocketing, cybersecurity threats piling up like never-ending junk mail, and operational hurdles lurking around every corner, Wipfli's throwing down the gauntlet for business leaders to wise up....

Continue Reading
Implantica's Q3 2026: A Potential Leap Forward?

Updated Category News Views 34

Implantica Prepares to Unveil Q3 Results We're heading into the home stretch for 2026, and Implantica's about to unveil its third-quarter results. With its presentation scheduled for November 19 at 15:00 CET, this medtech outfit has caught some eyes, especially with their flagship offering, RefluxStop®. Paying attention here might be worthwhile, as this plays into a...

Continue Reading
Squeez and Qentelli Join Forces to Revolutionize Loyalty

Updated Category News Views 438

A New Era of Loyalty Commerce The winds are changing in the loyalty game, and it's about time someone shook things up. Squeez has teamed up with Qentelli, thanks to a $1 million investment, to kick-start this next wave of commerce. And boy, it's not just about money—it's like combining brains with brawn. Squeez isn't just offering loyalty programs anymore; they're...

Continue Reading
Vipshop Sets 2026 AGM: Shareholders Meet on Dec 8

Updated Category News Views 21

Blockbuster or Bust: Vipshop's Upcoming AGM Here's the scoop: Vipshop Holdings Limited, with its mammoth operations in China's off-price retail sector, is gearing up for its annual general meeting (AGM) on December 8, 2026. This is where management and stakeholders will hash out everything from strategic pivots to financial health. Forget shareholder votes this...

Continue Reading

Top 5 Most Recently Viewed Articles

Actinium Pharmaceuticals Faces Class Action Lawsuit for Losses

Updated Category News Views 198

Actinium Pharmaceuticals: A Closer Look at the Lawsuit Recently, a significant class action lawsuit was filed against Actinium Pharmaceuticals, Inc. (NYSE: ATNM). This legal action is vital for investors who have experienced financial losses associated with their investments in Actinium's stock. The lawsuit, initiated by Pomerantz LLP, accuses the company and some of its...

Continue Reading
Uranium Energy Corp Delivers Promising Drill Results at Roughrider

Updated Category News Views 69

Uranium Energy Corp Unveils Outstanding Drilling Results Uranium Energy Corp (NYSE American: UEC) is thrilled to share the latest findings from its active drilling campaign at the Roughrider Project, which have revealed striking high-grade uranium mineralization. A drill hole positioned 850 meters northeast of the central Roughrider deposit has showcased remarkable...

Continue Reading
TME Pharma Presents Promising Glioblastoma Trial Outcomes

Updated Category News Views 159

TME Pharma's Progress in Glioblastoma Treatment TME Pharma N.V. is a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer. Recently, they announced an important oral presentation at a renowned medical congress, showcasing the encouraging results from the NOX-A12 GLORIA Phase 1/2 trial. This study aims to address glioblastoma, a...

Continue Reading
Life Time Champions Expanding Pickleball Facilities Across U.S.

Updated Category News Views 327

Life Time Champions Expanding Pickleball Facilities Across U.S. Life Time (NYSE: LTH) proudly marks World Pickleball Day as the sport continues to gain unprecedented popularity across America. With over 750 permanent pickleball courts established within its athletic country clubs, the organization demonstrates its commitment to being at the forefront of this dynamic...

Continue Reading
Edgewise Therapeutics Shares Breakthrough EDG-7500 Results

Updated Category News Views 305

Edgewise Therapeutics Announces Significant Progress in Hypertrophic Cardiomyopathy Treatment Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a pioneering biopharmaceutical company focused on muscle diseases, has recently disclosed positive outcomes from their Phase 2 CIRRUS-HCM trial studying EDG-7500. This treatment targets hypertrophic cardiomyopathy (HCM), a serious...

Continue Reading